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Post-translational modification of proteins in diabetes, including formation of advanced gly-
cation end products (AGEs) are believed to contribute to vascular dysfunction and disease.
Impaired function of the endothelium is an early indicator of vascular dysfunction in diabetes
and as many endothelial cell processes are dependent upon intracellular [Ca2+] and Ca2+
signaling, the aim of this study was to examine the acute effects of AGEs on Ca2+ signaling
in bovine aortic endothelial cells (BAEC). Ca2+ signaling was studied using the fluorescent
indicator dye Fura-2-AM. AGEs were generated by incubating bovine serum albumin with
0–250 mM glucose or glucose-6-phosphate for 0–120 days at 37˚C. Under all conditions,
the main AGE species generated was carboxymethyl lysine (CML) as assayed using both
gas-liquid chromatograph-mass spectroscopy and high-performance liquid chromatogra-
phy. In Ca2+-replete solution, exposure of BAEC to AGEs for 5 min caused an elevation in
basal [Ca2+] and attenuated the increase in intracellular [Ca2+] caused by ATP (100µM). In
the absence of extracellular Ca2+, exposure of BAEC to AGEs for 5 min caused an eleva-
tion in basal [Ca2+] and attenuated subsequent intracellular Ca2+ release caused by ATP,
thapsigargin (0.1µM), and ionomycin (3µM), but AGEs did not affect extracellular Ca2+
entry induced by the re-addition of Ca2+ to the bathing solution in the presence of any of
these agents.The anti-oxidant α-lipoic acid (2µM) and NAD(P)H oxidase inhibitors apocynin
(500µM) and diphenyleneiodonium (1µM) abolished these effects of AGEs on BAECs, as
did the IP3 receptor antagonist xestospongin C (1µM). In summary, AGEs caused an acute
depletion of Ca2+ from the intracellular store in BAECs, such that the Ca2+ signal stimu-
lated by the subsequent application other agents acting upon this store is reduced. The
mechanism may involve generation of reactive oxygen species from NAD(P)H oxidase and
possible activation of the IP3 receptor.
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INTRODUCTION
One of the earliest signs of vascular endothelial dysfunction
observed in diabetes is impairment of endothelium-dependent
vasodilatation. Impaired vasodilatation has been demonstrated
in a number of experimental, animal models of hyperglycemia
and diabetes (Tesfamariam et al., 1991; Fukao et al., 1997; De
Vriese et al., 2000; Young et al., 2008; Ding and Triggle, 2010)
as well as in clinical studies of both type 1 and type 2 dia-
betes subjects (McVeigh et al., 1992; Clarkson et al., 1996; Ting
et al., 1996). While high blood glucose levels alone may have an
inhibitory effect on endothelium-dependent vasodilatation (Crea-
ger et al., 2003; Gerich, 2003; Endemann and Schiffrin, 2004;
Hartge et al., 2006), a further consequence of hyperglycemia is the
enhanced formation of glycated species including advanced gly-
cation end products (AGEs), a reaction between glucose/glucose
metabolites and amine, guanidine and thiol groups on pro-
teins, and other long-lived macromolecules. AGE formation is
thought to contribute to many of the deleterious vascular effects
of diabetes (Goldin et al., 2006; Negre-Salvayre et al., 2009) includ-
ing impaired endothelium-dependent vasodilatation (Bucala et al.,
1991; Rodriguez-Manas et al., 1993; Vallejo et al., 2000; Gao et al.,
2008; Sena et al., 2012). AGEs may also damage the vasculature
by cross-linking extracellular matrix and other vascular proteins,
stiffening the vascular wall (Brownlee et al., 1986; Sims et al.,
1996) as well as through binding to specific receptors for AGE
(RAGE; Farmer and Kennedy, 2009; Yan et al., 2009), which sub-
sequently generates inflammatory mediators including reactive
oxygen species (ROS) and TNFα.
Formation of the key endothelium-derived vasodilator sub-
stance, nitric oxide (NO), and the activity of endothelium-derived
hyperpolarizing factors (EDHFs) is dependent on an increase
in endothelial cell [Ca2+]. Synthesis of NO from arginine by
NO synthase (NOS) is a process that is dependent on several
co-factors including Ca2+, the Ca2+-binding protein calmod-
ulin, oxygen, tetrahydrobiopterin, and NAD(P)H (Moncada and
Higgs, 2006). Although several candidate endothelium-derived
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hyperpolarizing (EDH) substances and mechanisms exist, Ca2+-
activated K+ channels (KCa) represent important common ele-
ments in their function. In endothelial cells, both intermediate-
and small-conductance KCa (IKCa and SKCa respectively) are
involved in most established EDH mechanisms (Feletou and Van-
houtte, 2009; Sandow et al., 2009). KCa require an increase in
cytoplasmic [Ca2+] in order to be activated. In addition to its
primary role in stimulating NOS and EDHF activity, and thus
initiating endothelium-dependent vasodilatation, endothelial cell
Ca2+ signaling is vital in regulating endothelial cell growth, pro-
liferation, and angiogenesis (Munaron and Fiorio Pla, 2009) along
with hemostasis and inflammatory responses (Hawkins et al.,
2007; Sadler, 2009).
Vascular endothelial cell [Ca2+] may be altered by a wide
variety of neural, humoral, and physical stimuli (Muller et al.,
1999; Kwan et al., 2007; Sandow et al., 2012). Receptor-mediated
increases generally involve activation of Gq/11-protein and phos-
pholipase C (PLC) and subsequent inositol 1,4,5-trisphosphate
(IP3)-mediated release of intracellular Ca2+ stores (Sandow et al.,
2012). The endoplasmic reticulum also possesses ryanodine recep-
tors and Ca2+-induced Ca2+ release occurs in these cells. Extracel-
lular Ca2+ entry is not through voltage-dependent Ca2+ channels
as vascular endothelial cells typically do not express them. Ca2+
entry is sensitive to the electrochemical gradient across the mem-
brane, such that Ca2+ entry is enhanced by hyperpolarization
and reduced by depolarization of endothelial cells. Extracellular
Ca2+ entry consists of a capacitive, store-operated component
(capacitive Ca2+ entry or CCE), activated by depletion of intra-
cellular stores, and/or entry through other mechanisms including
receptor-operated channels and membrane Ca2+-exchangers. The
mechanism of CCE into vascular endothelial cells is not fully
understood and is somewhat controversial (Beech, 2009), with
transient receptor potential (TRP) channels, the endoplasmic
reticulum Ca2+ sensor STIM1, and the plasma-membrane Orai1
channel all implicated in the mechanism (Beech, 2009; Sandow
et al., 2012). Receptor-operated channel mechanisms are primar-
ily associated with the activity of various TRP-canonical (TRPC)
and vanilloid (TRPV) subtypes (Sandow et al., 2012; Senadheera
et al., 2012; Sonkusare et al., 2012).
Only a few studies have examined the direct effects of AGEs and
other glycated species on endothelial cell Ca2+ signaling. In a pre-
vious study utilizing bovine aortic endothelial cells (BAEC) plated
on glycated mixed matrix (EHS) protein, ATP-, and thapsigargin-
induced increases in intracellular [Ca2+] were shown to be inhib-
ited (Bishara et al., 2002a), suggesting glycated proteins can inter-
fere with Ca2+ signaling in the endothelium. However the role of
AGEs in, and the time-course of, this response (cells were plated
on modified EHS for approximately 16 h) were not examined. Fur-
thermore, while endothelial cell viability was significantly reduced
by the glycated EHS matrix proteins it was noticeable that ATP-
induced Ca2+ signaling was not impaired in cells similarly exposed
to glycated fibronectin. Interestingly, the glycated fibronectin did
not markedly inhibit cell viability (Bishara et al., 2002a), suggest-
ing toxicity may have contributed to the effects of the glycated
EHS on Ca2+ signaling. Alternatively, the in vitro glycation pro-
cedure may have resulted in less extensive glycation of fibronectin
or generation of glycated species different to those present in
EHS (Bishara et al., 2002a). The present study, therefore, involved
in vitro glycation of bovine serum albumin (BSA) followed by
full characterization of the AGE species generated using a variety
of techniques including assay of unmodified amine groups, gas
chromatograph–mass spectroscopy (GC-MS), and reverse phase
high-performance liquid chromatography (HPLC). The effects of
exogenously applied AGEs on Ca2+ signaling in BAEC were then
examined. As many of the deleterious effects of AGEs are medi-
ated by the activation of RAGE and NAD(P)H oxidase (Farmer and
Kennedy, 2009; Warboys et al., 2009; Yan et al., 2009), the actions
of AGEs on Ca2+ signaling were also examined in the presence of
NAD(P)H oxidase inhibitors.
MATERIALS AND METHODS
PREPARATION OF GLYCATED PROTEIN
Bovine serum albumin (10 or 75 mg/ml in PBS, pH 7.4; 0.15
and 1.13 mM, containing 8.85 or 66.7 mM lysine respectively)
was incubated with varying concentrations of either glucose or
glucose-6-phosphate (G6P; 5–250 mM, 0.7–28 times excess over
lysine) for 5–90 days at 37˚C in the dark. The glycation reac-
tion was terminated by dialysis against fresh PBS. Prior to use in
experiments, AGE preparations were passed through Detoxi-Gel
AffinityPak™ columns to remove bacterial endotoxin. Endotoxin
levels in samples before and after column-purification were mea-
sured using a modified Limulus Amebocyte Lysate (LAL) test
(BioWhittaker, Inc., Walkersville, MD, USA) as per manufacturer’s
instructions. Samples used contained <0.01 EU/ml endotoxin
(lower limit of reliable detection).
ASSAY OF GLYCATED PROTEIN BY FLUORESCENCE, ABSORBANCE,
AND ASSAY OF UNMODIFIED AMINE GROUPS
The extent of protein glycation was determined by fluorescence
(Ex 370 nm/Em 440 nm) and absorbance (340 nm) measurements
together with an assessment of unmodified primary amines using
fluoraldehyde o-phthalaldehyde (OPA) crystals (Thermo Fisher
Scientific, Scoresby, VIC, Australia; see Roth, 1971).
ASSAY OF GLYCATED PROTEIN BY GAS-LIQUID
CHROMATOGRAPH-MASS SPECTROSCOPY
Gas-liquid chromatograph-mass spectroscopy (GC-MS) analysis
of samples was carried as described elsewhere (Dunn et al., 1991;
Dyer et al., 1991; Ahmed et al., 1997). Briefly, samples (containing
approximately 4 mg protein) were reduced in 100 mM of NaBH4
in 0.1 N NaOH for 16 h at 4˚C. Excess of NaBH4 was discharged
by addition of 10% trichloroacetic acid (w/v), samples were then
centrifuged at 2000× g and the precipitate resuspended in 0.1 N
NaOH. Acid hydrolysis was performed in 6 N HCl and the sam-
ples dried in vacuo and converted to their trifluoroacetyl methyl
ester (TFAME) derivatives for analysis. For preparation of TFAME,
1 ml freshly made 1 M methanolic HCl was added to the samples
and incubated for 45 min at 65˚C. Solvent was evaporated and the
product was redissolved in 1 ml of trifluoroacetic anhydride and
the mixture incubated at room temperature for 1 h to obtain the
trifluoroacetyl derivatives. After removing the solvent the sample
was dissolved in 150µl of methylene chloride and 2µl of this
solution was injected for GC/MS analysis.
Gas-liquid chromatograph/MS analyses were performed on a
Hewlett-Packard Model 5890 GC equipped with a Model 7673A
Frontiers in Physiology | Vascular Physiology March 2013 | Volume 4 | Article 38 | 2
Naser et al. AGEs and endothelial Ca2+ signaling
Autosampler and Model 5970 Mass Selective Detector, using a
30-m DB-5 capillary column (Agilent Technologies). The injec-
tion port was maintained at 275˚C and the transfer line at 290˚C.
The temperature program was as follows: 3 min at 130˚C; ramp
to 180˚C at 4˚/min and then to 240˚C at 5˚/min and to 290˚C at
15˚/min; hold for 5 min at 290˚C. Quantification was based on iso-
tope dilution using standard curves constructed from mixtures of
a constant amount of heavy labeled internal standards (d4CML,
d8CEL) and increasing amounts of non-labeled carboxymethyl
lysine (CML) and CEL. The limit of detection for GC/MS analysis
of CML and CEL was 0.05 and 0.007 mmol/mol of Lys respec-
tively, which is comparable with previous data (Miyata et al., 2000).
The coefficient of variation for detection of the analytes was 5%
(Dunn et al., 1991). The average CML and CEL recovery was 91%
(Petrovic et al., 2005).
ASSAY OF GLYCATED PROTEIN BY REVERSE PHASE HPLC
Glycated and control BSA samples (2 mg protein) were precipi-
tated and hydrolyzed (Nobecourt et al., 2010), derivatized using
o-phthaldialdehyde, and subjected to HPLC with fluorescence
detection as previously described (Zeng and Davies, 2005). Sam-
ples were separated (flow rate 1 ml/min) using a gradient of 85%
buffer A (96% 50 mM sodium acetate, pH 6.5, and 4% methanol;
v/v) and 15% buffer B (100% methanol) for 40 min; 15–50%
buffer B over 58 min; 50–90% buffer B for 2 min; 90% buffer
B for 2 min; 90–15% buffer B over 5 min; and re-equilibration
at 15% buffer B for 8 min. Identities of peaks were confirmed
by elution times and spiking with authentic materials. Peak
areas were converted to absolute levels using standard curves
constructed using authentic S-carboxymethylcysteine (CMC),
CML, CEL, (2S)-2-amino-5-(5-methyl-4-oxo-4,5-dihydro-1H-
imidazol-2-ylamino)-pentanoic acid (MG-H1), (2S)-2-amino-5-
(2-amino-5-methyl-4-oxo-4,5-dihydro-imidazol-1-yl)-pentanoic
acid acetate (MG-H2), glyoxal-derived lysine dimer (1,3-
bis(5-amino-5-carboxypentyl)-3H-imidazolium acetate; GOLD),
and methylglyoxal-derived lysine dimer (1,3-bis(5-amino-5-
carboxypentyl)-4-methyl-3H-imidazolium acetate; MOLD). The
limit of detection for any AGE using this HPLC method is 0.1 pmol.
BAEC CULTURE AND Ca2+ MEASUREMENTS
Bovine aortic endothelial cells (Cambrex Bio Science Australia Pty
Ltd.) were cultured in endothelial cell growth medium (BulletKit®;
Cambrex Bio Science Australia Pty Ltd.) at 37˚C in 5% CO2 (pas-
sages 3–7). Cells were allowed 72 h to adhere and become confluent
on sterile, single-well MatTek™ plates (MatTek Corporation, Ash-
land, MA, USA). Intracellular [Ca2+] in BAEC was measured using
the fluorescent, ratiometric dye Fura-2 AM. BAEC were washed
three times with Krebs solution (composition in mM: 111 NaCl,
25.7 NaHCO3, 4.9 KCl, 2.5 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 11.5
glucose, and 10 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic
acid, N -(2-Hydroxyethyl)piperazine-N ′-(2-ethanesulfonic acid;
HEPES) dissolved in double distilled water, pH 7.4) and incu-
bated with Fura-2 AM (2µM) at 37˚C for 30 min. After washing,
fluorescence measurements were performed in enclosed cover-
slip holders perfused with Krebs solution (composition described
above) at room temperature on a randomly selected area of 25
cells that were highly confluent with even dye loading. The Krebs
solution used to superfuse the cells during fluorescence measure-
ments was not gassed with CO2, our experience has shown HEPES
is sufficient to buffer the Krebs and any pH changes in the envi-
ronment of the cells over the brief time-course of the experiment
that, including the Fura-2 incubation period, was less than an hour
(Bishara et al., 2002a). Fluorescence measurements were made
using an Olympus CellR Real-Time Imaging Station (objective
40×; Olympus Australia Pty Ltd., Mt Waverley, VIC, Australia).
Images were collected at one image per 5, 15, or 30 s based on the
stage of experiment as shown on each graph. Changes in intra-
cellular [Ca2+] were expressed as the ratio of emission (510 nm)
following excitation at 340 and 380 nm. Data was normalized to the
baseline, which was defined as values obtained during the period
(1 min) immediately prior to intervention.
EXPERIMENTAL PROTOCOLS
Following Fura-2 loading, the cells were incubated with an AGE
preparation or control solution (the same concentration of BSA
incubated under identical conditions as the glycated samples, but
in the absence of glycating agent) for 5 min prior to addition of
a Ca2+ signaling agent. Fura-2 fluorescence was monitored from
1 min prior to the addition of the control or AGE sample and for
the following 11 min. To delineate effects on intracellular Ca2+
release and extracellular Ca2+ entry including CCE, BAECs were
incubated with Ca2+-free Krebs solution (containing no added
CaCl2) for 1 min prior to addition of the AGE preparation or con-
trol solution. Cells were then incubated with the AGE preparation
or control solution for 5 min before addition of one of ATP, thap-
sigargin, or ionomycin. Extracellular Ca2+ entry was induced by
subsequent addition of buffer containing CaCl2 (1 mM; Bishara
et al., 2002a), in the continued presence of ATP, thapsigargin, or
ionomycin, and fluorescence was recorded for an additional 5 min.
Where required, the anti-oxidant dl-α-lipoic acid (2µM), the
NAD(P)H oxidase inhibitors diphenyleneiodonium (DPI, 1µM)
or 4′-Hydroxy-3′-methoxyacetophenone (apocynin, 500µM) or
the IP3 receptor antagonist xestospongin C (1µM) were incubated
with BAECs for 30 min at 37˚C prior to the addition of AGE or con-
trol solutions. Where experiments varied from this protocol, such
deviations are described in the text. Appropriate buffer controls
were performed for these agents, the buffer controls had no effect
on the parameters measured in the present study (not shown).
DRUGS AND CHEMICALS
Quick Start™ Bradford assay and sodium dodecyl sulfate (SDS)
from Bio-Rad, Phosphate buffer saline tablets (PBS), Fura-2 AM,
and trypsin-EDTA from Invitrogen Australia Pty Limited (Mul-
grave, VIC, Australia), Detoxi-Gel Affinity Pack™ Pre-Packed
columns from Thermo Fisher Scientific Inc. (Mulgrave, VIC,
Australia), BSA from BOVOGEN (Essendon, VIC, Australia),
LAL QCL-1000 from BioWhittaker Inc., Water for Irrigation
from Baxter Healthcare Pty Ltd. (Old Toongabbie, NSW, Aus-
tralia), Endothelial growth medium (EGM) BulletKit® from Cam-
brex Bio Science Australia Pty Ltd., CML for HPLC from TRC
(ON, Canada), CEL, MG-H1, MG-H2, GOLD, and MOLD from
NeoMPS (Strasbourg, France). Unless otherwise stated, all other
drugs and chemicals were obtained from Sigma Aldrich Pty Ltd.
(Castle Hill, NSW, Australia).
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DATA ANALYSIS AND STATISTICAL METHODS
Overall changes in normalized fluorescence ratio are expressed as
AUC (area under curve) primarily because the response to AGEs
(as opposed to ATP) did not feature clear “peak” or “sustained”
phases, but a slowly developing and sustained increase. Calcula-
tion of AUC was performed using GraphPad Prism Version 4.01
(GraphPad Software Inc., La Jolla, CA, USA) with background
fluorescence subtracted (from a region of the cover slips not
containing cells). “Curves” were defined as the period between
which fluorescence ratio significantly exceeded and returned to
the basal level following an intervention, in other words elevations
in basal fluorescence caused by AGEs were excluded. Overall, flu-
orescence data for an individual experiment were normalized to
the baseline and presented as mean± SEM. Comparisons of the
means and SEMs of two groups were performed using unpaired
t -tests. Multiple comparisons were performed using two-way
ANOVA with Bonferroni post-tests. All other statistical opera-
tions were performed using GraphPad Prism 4.01. n is the number
of plates and represents at least three different batches of plated
cells.
RESULTS
CHARACTERIZATION OF GLYCATED BSA
Formation of AGEs in BSA solutions co-incubated with G6P or
glucose was dependent on both the duration of incubation and
concentration of glycating agent,as assessed by sample absorbance,
fluorescence, assay of unmodified amines (Figure 1) and GC-
MS (Figures 2A–D) and HPLC (Figures 2E–H). Analysis showed
CML to be the predominant AGE (of those assayed) formed in
the BSA samples, regardless of glycating agent (Figure 2). Of the
other AGEs, significant increases in CEL, MG-H1, and CMC were
also found, when compared with control BSA samples (Figure 2).
There was no significant increase in the formation of MG-H2,
GOLD, or MOLD (data not shown). G6P proved to be a more
effective glycating agent than glucose (Figures 1 and 2).
EFFECT OF GLYCATED BSA ON Ca2+ SIGNALING IN BAEC
The most extensively glycated BSA sample (10 mg/ml BSA incu-
bated with 250 mM G6P for 60 days), at a final concentration of
0.1 mg protein/ml, was used routinely to examine effects on Ca2+
signaling in BAEC. Control samples consisted of 0.1 mg/ml of
a 10 mg/ml BSA solution incubated without glycating agent for
60 days.
In endothelial cells bathed in normal (i.e., Ca2+-replete) Krebs
solution, exposure of the endothelial cells to the AGE sample alone
caused a significant increase in intracellular [Ca2+], whereas the
control sample did not increase [Ca2+] (Figure 3A). The differ-
ence in Ca2+ response was evident approximately 1 min. following
addition of the sample and reached a plateau after approximately
3 min. exposure (Figure 3A). In cells incubated with control
sample, subsequent exposure to ATP (100µM) caused a rapid
increase in intracellular [Ca2+] (compared with the AGEs-induced
increase) consisting of an early, transient increase peaking at
approximately threefold the normalized basal fluorescence ratio,
followed by a sustained increase in fluorescence ratio at about
1.5 times the basal level (Figure 3A). Exposure of cells to the
AGE-containing sample significantly attenuated the ATP-induced
FIGURE 1 | Glycation of BSA (10 mg/ml) during co-incubation with
G6P (open symbols) or glucose (filled symbols), as assessed by the
decline in free amine groups (A), sample fluorescence (B), and sample
absorbance (C). Symbols represent the mean±SEM for three separate
batches of BSA glycated under identical conditions and each sample was
read in triplicate.
increase in [Ca2+] (compared to the pre-ATP,“baseline”level) with
an apparently selective effect on the early, transient component
(Figure 3A).
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FIGURE 2 | Concentrations of various AGE in samples of
co-incubated BSA and glycating agent analyzed using GC-MS
(A–D) or HPLC [(E–H); see list of abbreviations for individual AGE
species definitions]. Columns in (A–D) represent a triplicate reading of
a single sample; columns in (E–H) represent the mean±SEM for three
separate batches of BSA glycated under identical conditions and each
sample was read in duplicate. *Indicates significant increase from
control (P <0.05, t -test).
The effect of AGEs on the different components of Ca2+ sig-
naling were investigated further by superfusing the cells with
Ca2+-free and Ca2+-replete buffer solutions. In the absence of
extracellular Ca2+, all increases in intracellular [Ca2+] are due
to the release of Ca2+ from intracellular stores only. Under these
conditions, AGEs alone caused a sustained increase in intracellular
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FIGURE 3 | Effect of AGEs on ATP-induced Ca2+ signaling in BAEC. (A)
In the presence of extracellular Ca2+, AGEs alone induced an increase in
[Ca2+] and inhibited the subsequent ATP-induced Ca2+ increase, as shown
in the inset (Area Under Curve data). (B) In the absence of extracellular
Ca2+, AGEs alone induced an increase in [Ca2+], inhibited ATP-induced
intracellular Ca2+ release but did not affect CCE upon the re-addition of
extracellular Ca2+ (CaCl2). Points and columns represent the mean±SEM
of five to six recordings. *Indicates significant effect of AGEs compared to
control (P <0.05, t -test).
[Ca2+] (Figure 3B), although the [Ca2+] increase was significantly
less than that observed in Ca2+-containing buffer. In the absence
of extracellular Ca2+, AGEs inhibited the following ATP-induced
release of intracellular Ca2+ (Figure 3B). In contrast, the increase
in [Ca2+] following re-introduction of Ca2+-containing buffer
was not significantly altered by the glycated protein (Figure 3B),
suggesting a specific effect on the Ca2+-release component. Fur-
ther, re-addition of Ca2+-replete buffer to the cells in the presence
of AGEs only (i.e., in the absence of ATP) showed that AGEs
alone could induce extracellular Ca2+ entry (Figure 4A). When
the order of AGEs and ATP application to the cells was reversed
(that is, AGEs were added following ATP), AGEs did not cause an
increase in intracellular Ca2+ (Figure 4B), suggesting AGEs and
ATP released Ca2+ from the same intracellular “pool.” Under this
protocol, AGEs enhanced subsequent Ca2+ entry caused by the
re-addition of Ca2+-containing buffer to the cells (Figure 4B).
Additional experiments were subsequently performed to exam-
ine the effects of AGEs on endothelial cell intracellular Ca2+ release
induced by thapsigargin, an inhibitor of endoplasmic reticulum
FIGURE 4 | Effect of AGEs on Ca2+ signaling in BAEC. (A) In the absence
of extracellular Ca2+, AGEs alone induced an increase in [Ca2+] and induced
significant CCE compared with control (unglycated BSA). (B) In the absence
of extracellular Ca2+, AGEs added to the BAEC after ATP did not induce an
increase in [Ca2+], but increased CCE (CaCl2). Points and columns represent
the mean±SEM of six recordings. *Indicates significant effect of AGEs
compared to control (P <0.05, t -test).
Ca2+-ATPase pump which causes emptying of intracellular Ca2+
stores, and ionomycin which acts directly on the intracellular Ca2+
storage organelle to empty the store. In the absence of extracel-
lular Ca2+, AGEs inhibited intracellular Ca2+ release in response
to either thapsigargin (0.1µM; Figure 5A) or ionomycin (3µM;
Figure 5B). Under both of these protocols, AGEs again did not
affect Ca2+ entry induced by the re-addition of Ca2+-containing
buffer to the cells; in this case, such entry may be termed capacitive
Ca2+ entry or CCE, as these agents have not been shown to acti-
vate other Ca2+-entry mechanisms in vascular endothelial cells.
The time-course of the thapsigargin experiments was extended
slightly due to the prolonged time over which thapsigargin stimu-
lated Ca2+ release (Figure 5A). Collectively, these data support a
specific effect of AGEs on Ca2+ release from the endoplasmic retic-
ulum, consistent with partial depletion of the intracellular Ca2+
store.
EFFECTS OF THE EXTENT OF GLYCATION AND AGE CONCENTRATION
ON Ca2+ SIGNALING
The effects of AGEs on Ca2+ signaling were dependent upon both
the concentration of glycated BSA and the extent of glycation.
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FIGURE 5 | Effect of AGEs on thapsigargin (A) and ionomycin
(B)-induced Ca2+ signaling in BAEC, in the absence of extracellular
Ca2+. In both cases AGEs alone induced an increase in [Ca2+] and inhibited
the subsequent agent-induced Ca2+ increase, but did not affect CCE upon
the re-addition of extracellular Ca2+ (CaCl2). Points and columns represent
the mean±SEM of six recordings. *Indicates significant effect of AGEs
compared to control (P <0.05, t -test).
Figures 6A–C show the effects of the AGEs sample on basal [Ca2+]
and ATP-induced Ca2+ release were concentration dependent;
concentrations of this sample exceeding 0.2 mg/ml were shown to
be detrimental to cell viability as determined by propidium iodide
staining (not shown). In samples of BSA incubated under varying
conditions (concentration, time of exposure, and type of glycating
agent), there was a strong correlation between the concentration
of CML, taken as indicator of the extent of glycation, and inhibi-
tion of ATP-induced Ca2+ increase in BAEC (Figure 6D). The
inhibitor of advanced glycation aminoguanidine (25 mM), co-
incubated with the sample 50 mM G6P/10 mg/ml BSA/60 days,not
only prevented the accumulation of CML and MG-H1 in this sam-
ple (see Figure 2) but also prevented any effect on Ca2+ signaling
(Figure 6E).
The concentration of CML in 0.1 mg/ml of the AGE sample
was estimated to be approximately 0.6µM. Ten-fold of this con-
centration (6µM) of CML alone, as opposed to CML adducts
formed on glycated BSA, had no effect on Ca2+ signaling in
BAEC (Figure 6F), suggesting that while CML levels correlate with
extent of glycation they may not, themselves, directly impair Ca2+
signaling.
EFFECT OF ANTI-OXIDANT AND NAD(P)H OXIDASE INHIBITORS ON AGE
AND Ca2+ SIGNALING
A number of previous studies have suggested that the effects of
AGE are mediated by ROS, subsequent to activation of the enzyme
NAD(P)H oxidase (Farmer and Kennedy, 2009; Warboys et al.,
2009). The role of ROS and NAD(P)H oxidase in the effects of
AGEs on Ca2+ signaling in BAEC were examined using the anti-
oxidant α-lipoic acid (2µM) and the NAD(P)H oxidase inhibitors
apocynin (500µM) and DPI (1µM). Pre-incubation of the cells
with each of these compounds prevented both the AGEs-induced
release of intracellular Ca2+ and the inhibition of ATP-mediated
Ca2+ release caused by AGEs (Figures 7A–C). DPI alone signifi-
cantly inhibited CCE (Figure 7C). DPI and, to a lesser extent, lipoic
acid inhibited both components of ATP-induced Ca2+ signaling
(Figure 7).
ROLE OF IP3 IN EFFECTS ON AGE-INDUCED CHANGES IN Ca2+
SIGNALING
The role of IP3 in the effects of AGEs on Ca2+ signaling in BAEC
was investigated using the IP3 receptor antagonist xestospongin
C (1µM). In the presence of the IP3 blocker, AGEs significantly
increased basal [Ca2+] in the cells, but did not inhibit ATP-
induced Ca2+ release (Figure 8). The combination of AGEs and
xestospongin C significantly increased extracellular Ca2+ entry
compared with Ca2+ entry in the presence of the control sample
and xestospongin C (Figure 8). Xestospongin C did not interfere
with recording by fluorescing at the same wavelength as Fura (data
not shown).
DISCUSSION
Dysfunction of the vascular endothelium is an early and poten-
tially damaging vascular complication of diabetes which may
contribute to the vascular complications associated with diabetes.
AGEs formed following prolonged exposure of plasma and matrix
proteins and other macromolecules to increased blood glucose are
known to cause endothelial dysfunction (Wautier and Schmidt,
2004; Goldin et al., 2006). As many of the functions of vascular
endothelial cells depend upon Ca2+ signaling, this study exam-
ined the effects of acute exposure to AGEs on Ca2+ signaling
in endothelial cells. Incubation of the cells with AGEs caused
an acute depletion of intracellular Ca2+ stores, the emptying of
these stores resulting in an AGE-induced increase in cell [Ca2+].
The initial increase in endothelial cell [Ca2+] caused by agonists
such as ATP, along with agents including ionomycin and thapsi-
gargin, is also due to the release of these stores; prior incubation
with AGE depletes these stores and therefore less releasable Ca2+
is available for the other agents (e.g., ATP), thus ATP-induced
[Ca2+] release was inhibited during this period. The sustained
phase of the ATP-induced [Ca2+] increase is due to influx of
extracellular Ca2+ and, as established by subsequent experiments,
this component of the endothelial cell [Ca2+] increase does not
appear to be altered by AGE. This is possibly because AGEs alone
induced CCE or Ca2+ entry through activation of intracellular
Ca2+ stores, thus complicating such observations. These effects
of AGEs on Ca2+ signaling may be mediated by superoxide or
its derivatives as they were prevented by inhibitors of NAD(P)H
oxidase.
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FIGURE 6 | Concentration dependence of AGE effects on Ca2+
signaling in BAEC (A–C). (D) Correlation between CML content and
inhibition of ATP-induced Ca2+ increase in BAEC of various AGE
samples [(A), 250 mM glucose/90 days; (B), 250 mM G6P/60 days; (C),
50 mM G6P/60 days; (D), 250 mM glucose/60 days; (E), 0.2 mg/ml of
250 mM G6P/60 days; (F), 0.05 mg/ml of 250 mM G6P/60 days]. (E)
AGE sample (50 mM G6P/60 days) co-incubated with aminoguanidine
(AG, 25 mM) did not alter Ca2+ signaling, compared with AGE not
containing AG. (F) CML (6µM) did not alter Ca2+ signaling in BAEC.
Points and columns represent the mean±SEM of five to six
recordings. *Indicates significant effect of AGE compared to control
(P <0.05, t -test).
Frontiers in Physiology | Vascular Physiology March 2013 | Volume 4 | Article 38 | 8
Naser et al. AGEs and endothelial Ca2+ signaling
FIGURE 7 | α-Lipoic acid (A), apocynin (B), and DPI (C) each abolished
the effects of AGEs on Ca2+ signaling in BAEC. Points and columns
represent the mean±SEM of 6–11 recordings.
Advanced glycation end products were formed by incubation
of BSA with glucose or G6P and the individual AGE adducts gener-
ated were quantified using GC-MS and HPLC. G6P proved a more
effective glycating agent than glucose, as others have observed pre-
viously (Bierhaus et al., 1998; Singh et al., 2001; Valencia et al.,
2004) and CML was by far the most abundant adduct formed,
exceeding that of the next most abundant AGEs assayed (CEL
and MG-H1) by at least 20-fold. Previous studies have shown the
plasma concentration of CML correlates with the severity of dia-
betic complications such as retinopathy and nephropathy (Reddy
et al., 1995; Furth, 1997; Wagner et al., 2001). Furthermore, in
FIGURE 8 | Xestospongin C attenuated the effects of AGEs on basal
[Ca2+] and abolished the effects on ATP-induced Ca2+ release, however
AGEs, in the presence of xestospongin C, enhanced CCE. Columns
represent the mean±SEM of six recordings. *Indicates significant effect of
AGEs compared to control (P <0.05, t -test).
adults with diabetes as well as adolescents and children with Type
1 diabetes, serum CML levels were significantly elevated, particu-
larly in those with microvascular complications and the plasma
concentration of CML in these patients similar to that in the
in vitro glycated samples generated in the present study (Berg
et al., 1998; Hwang et al., 2005; Alkhalaf et al., 2012). Concentra-
tions of the dominant AGE product (CML) in non-diabetic adults
are reported between 0.6 and 1.76 mmol/mol lysine, increasing
up to 1.33–2.37 mmol/mol lysine in Type 1 diabetic subjects with
microvascular complications (Dyer et al., 1993; McCance et al.,
1993), varying dependent upon the age of the subjects, vascular
complication status, and the analytical methods used for measure-
ment (Dyer et al., 1993; McCance et al., 1993; Semba et al., 2010;
Alkhalaf et al., 2012). In the current study, the final concentra-
tion of CML in the “standard” AGE used (0.1 mg/ml of 250 mM
G6P and 10 mg/ml BSA, 60 days) was 3.3–4.0 mmol/mol lysine,
similar in magnitude to those concentrations reported in diabetic
patients. Several studies have demonstrated significant glycation
of albumin in various cohorts of diabetic patients, with the per-
centage of glycation similar to or exceeding that of the most heavily
glycated sample utilized in the present study as assessed by fluo-
rescence, absorbance, and unreacted amine measurements (about
35% glycation; Rondeau and Bourdon, 2010; Kim and Lee, 2012).
It would therefore be reasonable to assume that the glycation reac-
tions used in the present study yielded physiologically relevant
concentrations of glycated albumin and CML and provided a valid
basis for studying the effects of AGEs in vitro.
Several observations support the idea that AGEs inhibited Ca2+
signaling in the endothelial cells by causing a relative depletion of
the intracellular Ca2+ stores. AGEs alone caused an increase in
intracellular [Ca2+], both in the presence and absence of extracel-
lular Ca2+. In the absence of extracellular Ca2+, AGEs inhibited
the release of intracellular [Ca2+] caused by three different mech-
anisms; IP3-mediated release (using ATP; see also Lynch et al.,
1992; Bishara et al., 2002b; Kwan et al., 2009), prevention of
Ca2+ uptake into the stores through inhibition of Ca2+-ATPase
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(thapsigargin) and by the Ca2+ ionophore ionomycin, which acts
directly upon the storage organelle membrane (Kauffman et al.,
1980; Bolger et al., 1983). AGEs alone could induce extracellular
Ca2+ entry (Figure 4A), most likely CCE as this is a phenomenon
reliant upon depletion of intracellular Ca2+ stores (in particu-
lar the endoplasmic reticulum; Parekh, 2006) and AGEs failed to
increase intracellular [Ca2+] when added to the cells following
store depletion using ATP. These observations suggested the AGE-
releasable pool of intracellular Ca2+ was at least the same size as,
if not a subset of, the ATP (i.e., IP3)-releasable pool. Collectively,
these observations suggest that AGEs inhibited ATP-, thapsigargin-
, and ionomycin-induced intracellular Ca2+ release by depleting
the pool of available Ca2+ acted upon by these agents. CCE was not
affected by AGEs and, when AGEs were added to the cells follow-
ing ATP, or when IP3 receptors were blocked, extracellular Ca2+
entry was enhanced, suggesting the glycated proteins may have an
action to induce Ca2+ entry or enhance CCE into the BAEC. It
should be noted that, unlike thapsigargin and ionomycin, ATP-
induced influx of extracellular Ca2+ into vascular endothelial cells
probably occurs by mechanisms additional to CCE, mostly likely
receptor-operated channels such as TRPC1, 3, and 4 (Kamouchi
et al., 1999; Brough et al., 2001; Freichel et al., 2001; Sandow et al.,
2012), along with other possible channels (Kwan et al., 2009) and
membrane Ca2+-exchangers such as Na+-Ca2+ (Berra-Romani
et al., 2010). The mechanism of CCE into vascular endothelial
cells is not fully understood and somewhat controversial (Beech,
2009) with various TRP channels identified as being involved in
the process (Cioffi et al., 2005; Antoniotti et al., 2006; Senadheera
et al., 2012; Sonkusare et al., 2012) along with the proteins cru-
cial for ICRAC, Stim1, and Orai1 (Abdullaev et al., 2008; Hirano
et al., 2009; Antigny et al., 2011). The mechanism of CCE was not
addressed in the present study, but the fundamental point is that
acute exposure to AGEs did not inhibit extracellular Ca2+ entry
following store depletion and re-addition of Ca2+, under several
different experimental, and mechanistically distinct, conditions.
The current study supports the conclusions of Bishara et al.
(2002a), in which BAEC or rat heart endothelial cells were co-
cultured with glycated matrix proteins (EHS) overnight (16 h).
These cells showed elevated basal [Ca2+] and impaired ATP-
, bradykinin-, and thapsigargin-induced Ca2+ signaling, which
was suggested to be due to depletion of intracellular Ca2+. The
co-culture procedure had a significant, negative effect on cell via-
bility, and the present study utilized AGE concentrations that did
not alter BAEC viability. AGEs also inhibited both intracellu-
lar [Ca2+] release and CCE in human mesangial cells following
60 min exposure (Mene et al., 1999), suggesting effects of AGEs on
CCE may develop with chronic, rather than acute exposure. AGEs-
induced apoptosis of BAEC was also associated with increased
[Ca2+], an effect also observed in the absence of extracellular
Ca2+ (Xiang et al., 2006). Oxidative stress was observed to con-
tribute to both increased Ca2+ and apoptosis in these studies
(Xiang et al., 2006; Hung et al., 2010). Prolonged exposure to AGEs
(96 h) increased intracellular [Ca2+] and enhanced sphingosine-1-
induced Ca2+ responses in porcine coronary artery smooth muscle
cells (David et al., 2008), which the authors concluded was due
to enhanced activity of ryanodine receptors and Ca2+-induced
Ca2+ release. In mouse cardiac myocytes,over-expression of RAGE
decreased cytosolic Ca2+, but exposure to AGEs for 24 h prolonged
excitation-induced Ca2+ transients (Petrova et al., 2002). These
effects may be explained by AGE-induced depletion of intracellular
Ca2+ and induction of Ca2+ influx respectively.
The role of AGEs in the effects on Ca2+ signaling, rather than
other potential protein modifications caused by the co-incubation
of BSA and d-glucose or G6P (e.g., oxidation or changes in tertiary
structure (Coussons et al., 1997) was implicated by the concen-
tration dependent effects of the glycated proteins and the strong
correlation between inhibition of ATP-induced Ca2+ release and
the extent of BSA glycation as measured by CML concentration.
Furthermore, preparations incubated with the glycation inhibitor
aminoguanidine, which prevented AGE formation, had no effect
on Ca2+ signaling in the BAECs. CML, the most abundant AGE
in the samples, did not alter Ca2+ signaling. This suggests that
CML-adducted BSA, rather than the CML itself, induced the Ca2+-
release and store depletion observed. Alternatively, it is possible
another AGE besides CML produced the observed effects on Ca2+.
For example, arginine-AGEs such as MG-H1 inhibit NOS and
other l-arginine-metabolizing and transporting enzymes present
in the vascular endothelium, although the concentrations required
are in excess of 1 mM (Brouwers et al., 2008; Lai et al., 2010).
The role of RAGE in the observed effects of AGE was not exam-
ined directly. The AGE receptor is known to exist constitutively
in some endothelial cell lines including BAEC (Basta et al., 2002;
Marx et al., 2004). It is likely that a receptor is involved in the
effects of the AGE, given the reasonably rapid increase in [Ca2+]
following exposure. The role of RAGE in the effects observed in
the present study requires further investigation.
Advanced glycation end products have been shown to stimu-
late ROS accumulation in vascular endothelial cells (Bierhaus et al.,
1997), including BAEC (Kislinger et al., 1999; Wautier et al., 2001;
Bishara et al., 2002a). ROS are thought to mediate many of the
deleterious effects of AGEs on vascular endothelial cells, including
decreased adhesion (Schmidt et al., 1995), increased permeability
(Warboys et al., 2009) and apoptosis (Xiang et al., 2006; Hung et al.,
2010) in addition to impaired NO production and endothelium-
dependent vasodilation. The results of the present study suggest
that the AGE-induced depletion of intracellular Ca2+ was medi-
ated by ROS derived from NAD(P)H oxidase as the general anti-
oxidant α-lipoic acid and NAD(P)H oxidase inhibitors apocynin
and DPI abolished the effects of AGE on Ca2+ signaling. Neither
of these inhibitors is selective; DPI also inhibits NOS and flavin
oxidase while apocynin has general anti-oxidant properties (Han-
cock and Jones, 1987; Stuehr et al., 1991; Heumuller et al., 2008;
Selemidis et al., 2008) but it has not been established that either
eNOS or flavin-containing enzymes other than NAD(P)H oxidase
are involved in Ca2+ signaling in these cells. It is worth noting that
DPI in particular greatly inhibited the ATP-induced Ca2+ response
of the cells although the relation between this observation and the
known actions of DPI remains to be elucidated. Other effects of
AGEs or RAGE activation (mostly on gene expression) involve the
activation of NAD(P)H oxidase, and are preventable by apocynin
and other inhibitors of this enzyme (Guo et al., 2008; Coughlan
et al., 2009; Farmer and Kennedy, 2009; Warboys et al., 2009). A
recent study showed a role for AGE-induced NAD(P)H oxidase
activity in the inhibition of endothelium-dependent vasodilation
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of coronary arterioles from diabetic mice (Gao et al., 2008) and
AGE-induced increases in microvascular permeability in the retina
(Warboys et al., 2009). These more “acute” responses are similar
in time-course to the increase in intracellular Ca2+ shown in the
present study. Glycated EHS increased the formation of H2O2
in BAEC (Bishara et al., 2002a) but, using similar fluorescence
detection methods, acute exposure to AGEs did not cause a mea-
sureable increase in H2O2 generation in the present study (results
not shown).
Previous work utilizing BAEC associated the effects of glycated
matrix proteins on Ca2+ signaling with increased intracellular
[IP3] (Bishara et al., 2002a). In the present study the IP3 receptor
antagonist xestospongin C attenuated the AGE-induced increase
in intracellular Ca2+ and abolished the inhibitory effect of AGEs
on ATP-induced Ca2+ release, suggesting the IP3 receptor was
involved in the effects of AGEs. AGE and RAGE have been shown
to activate PLC (Warboys et al., 2009; You et al., 2010); indeed, PLC
activation by RAGE may be a necessary step in the subsequent acti-
vation of NAD(P)H oxidase (Gao and Mann, 2009; Warboys et al.,
2009). This sequence of events would not implicate a role for ROS
in the Ca2+-releasing effects of AGEs. Alternatively, H2O2 was
shown to directly activate the IP3 receptor on the endoplasmic
reticulum in HUVEC, inducing Ca2+ release (Zheng and Shen,
2005) and similar findings have been made in other cell types
(Gonzalez et al., 2006; Takahashi et al., 2007; Gerich et al., 2009).
Other studies have suggested NAD(P)H oxidase derived O2 can
increase the sensitivity of the IP3 receptor in endothelial cells (Hu
et al., 2000; Madesh et al., 2005).
In summary, AGEs can act acutely to release intracellular Ca2+
in BAEC and induce Ca2+ influx, most likely CCE, in vascular
endothelial cells and this action may thus inhibit Ca2+ signal-
ing by physiological agents such as ATP, which also act through
these mechanisms. Acute exposure to AGE does not impair CCE
and extracellular Ca2+ entry and may in fact enhance it. These
actions of AGE appear to be mediated by ROS, possibly gen-
erated from NAD(P)H oxidase. There may be a role for IP3
receptors in these actions, although this remains to be estab-
lished. Clearly such rapid and significant effects on Ca2+ signaling
in vascular endothelial cells may play a significant role in the
effects of AGEs and diabetes on the Ca2+-dependent processes
in these cells, including those which impact the regulation of
vascular tone.
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APPENDIX
FIGURE A1 | Effect of AGEs on ACh-induced vasodilatation of arterioles
from rat cremaster muscles. Arterioles were cannulated and maintained
at 70 mmHg. (B) Five minutes exposure to AGEs inhibited ACh-induced
vasodilatation (n=9; p-value 0.011, two-way ANOVA). (A) Arterioles infused
with control AGEs solution did not affect ACh-induced vasodilatation (n=9;
p-value>0.05, two-way ANOVA). AGEs were produced by exposing BSA
(10 mg/ml) to 250 mM G6P for 60 days. For control AGEs solution, BSA
(10 mg/ml) exposed to 0 mM G6P was used. Data are expressed relative to
the maximum diameter obtained under passive conditions (in the absence
of extracellular calcium) at 70 mmHg. Points represented mean±SEM.
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